BioCryst Pharmaceuticals sues Hetero with claims of Orladeyo patent infringement. Orladeyo generated $437.7 million in revenue for BioCryst last year. BioCryst seeks court order to prevent FDA ...
HHS doesn’t have oversight over all food and nutrition products and policies. Nor does the Food and Drug Administration, ...
The FDA and HHS announced "Operation Stork Speed" Tuesday, which aims to increase testing for heavy metals and other ...
When the FDA announced in January, before President Joe Biden's term ended, that it would ban a dye called red dye No. 3 in ...
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies ...
The Trump administration halted some food testing and shut down a committee studying bacteria in infant formula. Earlier funding cutbacks under the Biden administration now threaten state labs and ...
Proscia has raised $50 million in fresh capital, bringing the Center City digital pathology services company's total funding ...
Which restaurants use beef tallow? Is it a better alternative to seed oil? Why did McDonald's stop using tallow, aka beef ...
Steak ‘n Shake has switched to beef tallow, describing the move as “RFK’ing” its fries — and Kennedy wants more restaurants ...
A subcommittee advanced a package dubbed the "Florida Farm Bill." Targets include "any additive" to water "for health-related ...
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback